On 10/30/2012, 8298554 patent for 885 should be issued. This is a composition patent--which recognizes that Vascepa is different than Lovaza.
NCE is only for 5 years--but after NCE expiry--Generics try to sell--but Patents keep them out.
Lipitor's generics by Ranbaxy were stopped because of patents.
Not sure its key to NCE
its a good protection patent in that Pure EPA tends to degrade quickly hence a short shelf life. But this patent does not provide improved theraputic value - nonetheless - a patent is a good thing
Sentiment: Strong Buy